| P50 | author | Geertruida H de Bock | Q37842361 |
| | Bert van der Vegt | Q50889999 |
| P2093 | author name string | Alex L T Imholz | |
| | Henk J Buikema | |
| | Maarten Louwen | |
| | Maria M Smits | |
| | Mariska Hage | |
| | Timco Koopman | |
| P2860 | cites work | The Measurement of Observer Agreement for Categorical Data | Q26778373 |
| | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial | Q27851578 |
| | HER2 testing in gastric cancer: a practical approach | Q28256814 |
| | Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities | Q33612658 |
| | HER2 amplification in gastroesophageal adenocarcinoma: correlation of two antibodies using gastric cancer scoring criteria, H score, and digital image analysis with fluorescence in situ hybridization | Q33863322 |
| | Image analysis as an adjunct to manual HER-2 immunohistochemical review: a diagnostic tool to standardize interpretation | Q34044859 |
| | HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions. | Q34324291 |
| | Updated UK Recommendations for HER2 assessment in breast cancer | Q35048548 |
| | HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma. | Q35111575 |
| | Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays | Q35318918 |
| | Optimizing HER2 assessment in breast cancer: application of automated image analysis | Q35673706 |
| | Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas | Q35681702 |
| | Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies | Q35686959 |
| | Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention | Q36120729 |
| | Assessment of a HER2 scoring system for gastric cancer: results from a validation study | Q37142266 |
| | HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target | Q37149210 |
| | Quantitation of HER2/neu expression in primary gastroesophageal adenocarcinomas using conventional light microscopy and quantitative image analysis | Q37251780 |
| | Comparing subjective and digital image analysis HER2/neu expression scores with conventional and modified FISH scores in breast cancer | Q39792766 |
| | Digital image analysis of membrane connectivity is a robust measure of HER2 immunostains | Q39980300 |
| | Image analysis of immunohistochemistry is superior to visual scoring as shown for patient outcome of esophageal adenocarcinoma | Q40217601 |
| | Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistry | Q40324533 |
| | HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing | Q42431264 |
| | Image cytometric HER2 in gastric carcinoma: is a new algorithm needed? | Q44196543 |
| | Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis. | Q53128686 |
| | Pathologic diagnostics of HER2 positivity in gastroesophageal adenocarcinoma. | Q53163402 |
| | Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II study. | Q53252056 |
| | HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison. | Q53657591 |
| | Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update | Q57130157 |
| P433 | issue | 2 | |
| P921 | main subject | biopsy | Q179991 |
| | adenocarcinoma | Q356033 |
| | immunohistochemistry | Q899285 |
| P304 | page(s) | 191-200 | |
| P577 | publication date | 2017-07-26 | |
| P1433 | published in | Histopathology | Q1524040 |
| P1476 | title | Digital image analysis of HER2 immunohistochemistry in gastric- and oesophageal adenocarcinoma: a validation study on biopsies and surgical specimens | |
| P478 | volume | 72 | |